Is This Biotech Stock After Groundbreaking Approval?
A breakthrough approval can move a biotech stock in dramatic ways. This guide breaks down how to assess the upside, m...
Identifying warning signs of poor retirement planning is essential for financial health. Learn how to act now for a more secure retirement.
15,260 articlesA breakthrough approval can move a biotech stock in dramatic ways. This guide breaks down how to assess the upside, m...
When Oshkosh released its latest results, the focus quickly shifted to a sharp stock move. This guide explains what h...
Wolfspeed has bounced on recent news, but deep profitability and liquidity issues linger. This guide breaks down the ...
HSBC downgraded Trade Desk to Reduce with a $20 target, joining a wave of caution as ad-tech faces a shift toward ret...
A strong earnings beat and improving fundamentals pushed Barrick's stock higher. This article breaks down the factors...
Canaccord Genuity boosts its price target on Plug Power to $4, citing early wins from Project Quantum Leap. The firm ...
Oklo faces a pivotal Q1 2026 earnings night as it pivots from regulatory progress to early commercial milestones. Wat...
Ford shares jumped roughly 7% as Q1 momentum and Ford Pro strength lifted the full-year EBIT outlook, putting Ford ah...
Stellantis stands at a defining juncture. A strategic call on brand focus and EV spending could reshape profitability...
BTIG raises its CrowdStrike price target to $621 from $499, signaling strong momentum in platform consolidation among...
Cisco surprised investors with strong quarterly results and higher guidance, boosting its stock and signaling robust ...
Barclays boosts its view on Charles Schwab after the firm guides for higher 2026 revenue and reports stronger Q1 resu...